Panbela Therapeutics (PBLA) has released an update to notify the public and investors about a material modification to rights of security holders.
The information provided in Item 1.01 has been incorporated into Item 3.03 of the Current Report as necessary.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.
